IRCT20200907048646N1招募中3 期
Evaluation of the effect of carvedilol in the prevention of cardiovascular complications induced by (5fu (5Fluorouracil) therapy in gastrointestinal cancer (GI) patients
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •All gastrointestinal cancer patients in the age range of 18 to 80 years old underwent 5FU therapy.
- •LVEF (left ventricular Ejection Fraction)>50%
排除标准
- •Patients with IHD (history of PCI, CABG, and Plavix consumption )
- •Mitral stenosis and cardiomyopathy
- •ECG changes characteristic to ischemia (ST-elevation more than 0.5mm and ST-depression more than 1 mm)
- •Acute myocardial ischemia at any stage of the study (ECG changes characteristic to ischemia, increased cardiac enzymes, or ischemic manifestations on echocardiography).
研究者
相似试验
尚未招募
不适用
S1501 Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients with Metastatic HER-2+ Breast Cancer, Phase III”NeoplasmsKCT0004843ational Cancer Center20
已完成
3 期
Assessment the effect of Carvedilol in preventing Heart failure in breast cancer patients.IRCT2017042433619N1Vice chancellor for research of Baqiyatallah University of Medical Sciences50
已完成
2 期
Study the preventive effect of Carvedilol therapy against Adriamycin-induced acute cardiotoxicity in breast cancer patients by measurement of myocardial deformation indexCongestive heart failureCondition 1: breast cancer. Condition 2: heart failure.Breast, unspecifiedIRCT2013093012924N1Vice chancellor for research, Mashhad University of Medical Sciences70
招募中
3 期
Effect of Carvedilol on Reducing Transtosomab Cardiac ComplicationsIRCT20190628044046N1Tehran University of Medical Sciences60
已完成
3 期
Evaluation of Early Disease in Familial Dilated CardiomyopathyFamilial dilated cardiomyopathyCardiovascular - Other cardiovascular diseasesACTRN12605000204640St Vincent's Hospital, Darlinghurst64